These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38160854)

  • 21. Everolimus-induced mTOR inhibition selectively depletes macrophages in atherosclerotic plaques by autophagy.
    Martinet W; Verheye S; De Meyer GR
    Autophagy; 2007; 3(3):241-4. PubMed ID: 17224626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice.
    Ye D; Yang X; Ren L; Lu HS; Sun Y; Lin H; Tan L; Wang N; Nguyen G; Bader M; Mullick AE; Danser AHJ; Daugherty A; Jiang Y; Sun Y; Li F; Lu X
    Front Cardiovasc Med; 2021; 8():725203. PubMed ID: 35004870
    [No Abstract]   [Full Text] [Related]  

  • 23. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
    Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
    Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma.
    Zhang X; Chen W; Fan J; Wang S; Xian Z; Luan J; Li Y; Wang Y; Nan Y; Luo M; Li S; Tian W; Ju D
    Carcinogenesis; 2018 May; 39(5):689-699. PubMed ID: 29538621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosuvastatin exerts anti-atherosclerotic effects by improving macrophage-related foam cell formation and polarization conversion via mediating autophagic activities.
    Zhang X; Qin Y; Wan X; Liu H; Lv C; Ruan W; He L; Lu L; Guo X
    J Transl Med; 2021 Feb; 19(1):62. PubMed ID: 33568202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis.
    Rasheed A; Robichaud S; Nguyen MA; Geoffrion M; Wyatt H; Cottee ML; Dennison T; Pietrangelo A; Lee R; Lagace TA; Ouimet M; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1155-1167. PubMed ID: 32212851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective clearance of macrophages in atherosclerotic plaques by autophagy.
    Verheye S; Martinet W; Kockx MM; Knaapen MW; Salu K; Timmermans JP; Ellis JT; Kilpatrick DL; De Meyer GR
    J Am Coll Cardiol; 2007 Feb; 49(6):706-15. PubMed ID: 17291937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huayu Qutan Recipe promotes lipophagy and cholesterol efflux through the mTORC1/TFEB/ABCA1-SCARB1 signal axis.
    Li Y; Pan J; Yu JJJ; Wu X; Yang G; Pan X; Sui G; Wang M; Cheng M; Zhu S; Tai H; Xiao H; Xu L; Wu J; Yang Y; Tang J; Gong L; Jia L; Min D
    J Cell Mol Med; 2024 Apr; 28(8):e18257. PubMed ID: 38526033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of total flavonoids of Ziziphora clinopodioides in improving atherosclerosis by regulating PI3K/Akt/mTOR pathway].
    Ma XY; Zhao HR; Qiao HL; Zeng YC; Zhang XM
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(2):465-471. PubMed ID: 36725236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.
    Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W
    Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of Pro-resolving and Pro-efferocytic Nanoparticles for Atherosclerosis Therapy.
    Patel Y; Manturthi S; Tiwari S; Gahunia E; Courtemanche A; Gandelman M; Côté M; Gadde S
    ACS Pharmacol Transl Sci; 2024 Oct; 7(10):3086-3095. PubMed ID: 39416959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive oxygen species-responsive nano-platform with dual-targeting and fluorescent lipid-specific imaging capabilities for the management of atherosclerotic plaques.
    He Z; Chen Q; Duan X; Zhong Y; Zhu L; Mou N; Yang X; Cao Y; Han Z; He H; Wu S; Wang G; Qin X; Qu K; Zhang K; Liu J; Wu W
    Acta Biomater; 2024 Jun; 181():375-390. PubMed ID: 38734284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-761 modulates foam cell formation and inflammation through autophagy in the progression of atherosclerosis.
    Wang C; Yang W; Liang X; Song W; Lin J; Sun Y; Guan X
    Mol Cell Biochem; 2020 Nov; 474(1-2):135-146. PubMed ID: 32772311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
    Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
    Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-protein diets increase cardiovascular risk by activating macrophage mTOR to suppress mitophagy.
    Zhang X; Sergin I; Evans TD; Jeong SJ; Rodriguez-Velez A; Kapoor D; Chen S; Song E; Holloway KB; Crowley JR; Epelman S; Weihl CC; Diwan A; Fan D; Mittendorfer B; Stitziel NO; Schilling JD; Lodhi IJ; Razani B
    Nat Metab; 2020 Jan; 2(1):110-125. PubMed ID: 32128508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNA-29a inhibits atherosclerotic plaque formation by mediating macrophage autophagy via PI3K/AKT/mTOR pathway.
    Shao W; Wang S; Wang X; Yao L; Yuan X; Huang D; Lv B; Ye Y; Xue H
    Aging (Albany NY); 2022 Mar; 14(5):2418-2431. PubMed ID: 35288486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNA-125b-1-3p mediates autophagy via the RRAGD/mTOR/ULK1 signaling pathway and mitigates atherosclerosis progression.
    Chen X; Cao Y; Guo Y; Liu J; Ye X; Li H; Zhang L; Feng W; Xian S; Yang Z; Wang L; Wang T
    Cell Signal; 2024 Jun; 118():111136. PubMed ID: 38471617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis.
    Bamezai S; Zhang Y; Kumari M; Lotfi M; Alsaigh T; Luo L; Kumar GS; Wang F; Ye J; Puri M; Manchanda R; Paluri S; Adkar SS; Kojima Y; Ingelsson A; Bell CF; Lopez NG; Fu C; Choi RB; Miller Z; Barrios L; Walsh S; Ahmad F; Maegdefessel L; Smith BR; Leeper NJ
    Nat Commun; 2024 Sep; 15(1):8034. PubMed ID: 39271657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FURIN suppresses the progression of atherosclerosis by promoting macrophage autophagy.
    Chen H; Zhang L; Mi S; Wang H; Wang C; Jia W; Gong L; Dong H; Xu B; Jing Y; Ge P; Pei Z; Zhong L; Yang J
    FASEB J; 2023 May; 37(5):e22933. PubMed ID: 37093709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.